1610537-15-9 Usage
General Description
VT-464 is a nonsteroidal, selective androgen receptor modulator (SARM) that has shown promise in the treatment of androgen receptor positive breast cancer and androgenic alopecia. It works by selectively targeting androgen receptors in the body, which allows for specific effects on muscle growth and bone density while minimizing potential side effects on other tissues. Research has demonstrated promising results in preclinical models, showing an ability to inhibit the proliferation of breast cancer tumors and promote hair growth in animal studies. Additionally, VT-464 has the potential to be used as a therapeutic agent for other androgen receptor related conditions, including prostate cancer and muscle wasting disorders. Overall, the development of VT-464 represents an exciting advancement in the field of androgen receptor modulation and may offer new treatment options for a range of conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1610537-15-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,1,0,5,3 and 7 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1610537-15:
(9*1)+(8*6)+(7*1)+(6*0)+(5*5)+(4*3)+(3*7)+(2*1)+(1*5)=129
129 % 10 = 9
So 1610537-15-9 is a valid CAS Registry Number.
1610537-15-9Relevant articles and documents
ANTICANCER COMPOUND PROCESS
-
, (2019/06/23)
The present invention relates to a process for preparing compound 1 that useful as an anticancer agent. In particular, the invention seeks to provide new methodology for preparing compound 1 and substituted derivatives thereof.
